These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9614834

  • 1. Leprosy reactions--complications of steroid therapy.
    Sugumaran DS.
    Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):10-5. PubMed ID: 9614834
    [Abstract] [Full Text] [Related]

  • 2. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK, Joshi B, Katoch K, Sengupta U.
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [Abstract] [Full Text] [Related]

  • 3. Some considerations on the origin of type 1 reactions in leprosy.
    Opromolla DV.
    Int J Lepr Other Mycobact Dis; 2005 Mar; 73(1):33-4. PubMed ID: 15898839
    [No Abstract] [Full Text] [Related]

  • 4. [The collateral effects of prolonged corticosteroid therapy].
    Genova R.
    Minerva Pediatr; 1969 Oct 27; 21(43):2026-38. PubMed ID: 4326808
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
    Parkash O, Girdhar BK.
    Acta Leprol; 1969 Oct 27; 12(2):63-9. PubMed ID: 12136738
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
    Sachdeva G, Kaur G, Bhutani LK, Bamezai RN.
    Int J Lepr Other Mycobact Dis; 1999 Jun 27; 67(2):133-42. PubMed ID: 10472365
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM, Martelli CM, Morais-Neto OL, Martelli P, Costa MB, de Andrade AL.
    Int J Lepr Other Mycobact Dis; 1998 Sep 27; 66(3):356-64. PubMed ID: 9934362
    [Abstract] [Full Text] [Related]

  • 13. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
    Reece ST, Ireton G, Mohamath R, Guderian J, Goto W, Gelber R, Groathouse N, Spencer J, Brennan P, Reed SG.
    Clin Vaccine Immunol; 2006 Mar 27; 13(3):333-40. PubMed ID: 16522774
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
    Salamatina OS, Diachina MN, Iushchenko AA, Chernousova LN, Kalinina ON, Parshin MP.
    Probl Tuberk; 2001 Mar 27; (8):49-51. PubMed ID: 11767394
    [Abstract] [Full Text] [Related]

  • 16. Clarification to Rada-Schlaefli, et al.
    Iyer A, Mistry N, Antia N, Harboe M.
    Int J Lepr Other Mycobact Dis; 2000 Mar 27; 68(1):63-4. PubMed ID: 10834071
    [No Abstract] [Full Text] [Related]

  • 17. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD, Gupta SK, Naraynan PR, Srivastava LM, Mishra RS, Talwar GP.
    Clin Exp Immunol; 1989 Nov 27; 78(2):214-8. PubMed ID: 12412751
    [Abstract] [Full Text] [Related]

  • 18. [Management of complications of steroid therapy].
    Hara M, Sasaki H.
    Nihon Rinsho; 1984 Nov 27; 42(11):2516-9. PubMed ID: 6442370
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.